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ABSTRACT 
 
1-(2-Chlorophenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carboxaldehyde (3) was synthesized by the reaction of (Z)-1-
(2-chlorophenyl)-2-(1-(thiophen-2-yl)ethylidene)hydrazine (2) and Vilsmeier-Haack (DMF, POCl3) reaction. The 
synthesised compound was characterized by spectroscopy and elemental analysis. The crystal structure was 
determined from single crystal X-ray diffraction data. It crystallizes in the triclinic crystal system with the space 
group P-1 and with unit cell parameters a= a = 7.2562(12) Å, b= 8.6896(11) Å, c =11.4407(16) Å ; α = 
109.168(7)º, β= 105.648(7)º, γ = 94.4099(8)º and Z = 2. The crystal structure is stabilized by intramolecular C---
H...O hydrogen bonds.   
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INTRODUCTION 
 
Pyrazoles and its derivatives, a class of well known nitrogen heterocycles, occupy a prime position in medicinal and 
pesticide chemistry for their diverse biological activities such as antioxidant [1,2], anticancer [3], anti-inflammatory 
[4], anticonvulsant [5], antipyretic [6], antimicrobial activities [7, 8]. Literature survey reveals that formylation of 
hydrazones yield formyl pyrazoles [1]. Formylation is a key process in organic synthesis in which the resulting 
aldehyde function acts as a crossroads intermediate, hence a large number of methods have been developed for this 
reaction. The Vilsmeier-Haack reaction is useful; method for the synthesis of 4-formyl pyrazoles, which can further 
be used as building blocks in the synthesis of complex molecules and biological active compounds. In view of this 
observation, we took the present task of synthesizing formyl pyrazoles with an in intention of getting more 
biological potency. 
 
EXPERIMENTAL SECTION 
 
The condensation of 2-acetyl thiophene (1) with 2-chloro phenylhydrazine hydrochloride in ethyl alcohol and a 
catalytic amount of acetic acid at water bath reflux condition produced (Z)-1-(2-chlorophenyl)-2-(1-(thiophen-2-
yl)ethylidene)hydrazine (2). Then, compound (2) was added to the Vilsmeier-Haack reagent prepared by drop-wise 
addition of POCl3 (1.2 mL) in ice cooled DMF (10 mL). The mixture was stirred at 60-65 oC for 6 h. The progress of 
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the reaction was monitored by TLC. After completion of the reaction, the mixture was poured into ice cold water, 
neutralized with NaHCO3, the solid separated was filtered, washed with ice cold water and recrystallized from 
ethanol to obtain target molecule 1-(2-chlorophenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carboxaldehyde (3) in 92% 
yield (Scheme-1). The product was purified by column chromatography using hexane:ethyl acetate (9:1 v/v) as 
eluent. Pure single crystal (light yellow) of the product was crystallized by the slow evaporation method using 
ethanol as a solvent, m.p. 134-135 °C. 
 
 
 
Melting point was determined by open capillary method and ia uncorrected. 1H NMR spectrum was recorded on 
Agilent vnmrs400MHz spectrometer using CDCl3 as a solvent and TMS as internal standard The Chemical shifts are 
expressed in δ ppm. Mass spectra were obtained on Shimadzu LCMS-2010A spectrophotometer (Chemical 
Ionization). Elemental analysis was obtained on a Thermo Finnigan Flash EA 1112 CHN analyzer. 
Chromatographic separations were carried out on silica gel (70-230 mesh, Merck) column using hexane: ethyl 
acetate (9:1) as eluent.  
 
Spectral analysis 
In 1H NMR spectrum, synthesized compound 1-(2-chlorophenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carboxaldehyde, 
(3) showed sharp singlet at δ 9.62 ppm. due to -CHO proton. A singlet for one proton absorbed at δ 8.46 ppm. was 
assigned to pyrazole ring proton. An array of signals observed as multiplet for seven protons in the region δ 7.20-
7.72 ppm. was due to aromatic benzene and thiophene rings protons. In its 13C NMR spectrum, compound, (3) 
showed an absorption signal due to -CHO carbon at δ 186.2 ppm. Signals observed at δ 136.1, 114.6 and 129.4 ppm. 
were due to C3-, C4- and C5-carbons of newly formed pyrazole ring. Four carbons of thiophene ring and six carbons 
of benzene ring showed the absorption signals at δ 127.1, 128.0, 129.3, 140.8 ppm. and δ 119.1, 122.4, 127.7, 130.7, 
133.9, 142.5 ppm. respectively. 
 
The mass spectrum of compound, (3) showed peak at m/z 290 with the relative intensity of 33%, which corresponds 
to molecular mass with 37Cl isotope. The base peak observed at m/z 288 corresponding to molecular ion with 35Cl 
atom. These peaks in the mass spectrum were in agreement with the molecular formula C14H9ClN2OS of the 
synthesized compound. Further, it showed satisfactorily analytical data for C, H and N atoms. Anal. Calcd. for 
C14H9ClN2OS: C, 58.23; H, 3.14; N, 9.70%; Found: C, 58.18; H, 3.17; N, 9.65%. 
 
The spectral and elemental analysis data proves the structure of 1-(2-chlorophenyl)-3-(thiophen-2-yl)-1H-pyrazole-
4-carboxaldehyde, (3). The structure proof was further confirmed by X-ray diffraction studies. 
 
 
X-Ray Data Collection, Structure Refinement and Crystal structure determination 
A light yellow rectangle shaped single crystal of dimensions 0.20×0.20×0.20 mm of the title compound was chosen 
for an X-ray diffraction study. X-ray intensity data were collected for the title compound at temperature 296 K on a 
Bruker Proteum2 CCD diffractometer with X-ray generator operating at 45 kV and 10 mA, using CuKα radiation of 
wavelength 1.54178 Å. Data were collected for 24 frames per set with different settings of φ (0° and 90°), keeping 
the scan width of  0.5°, exposure time of 5 s, the sample to detector distance of 45.10 mm and 2θ value at 46.6°.  A 
complete data set was processed using SAINT PLUS [9]. The structure was solved by direct methods and refined by 
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full-matrix least squares method on F2 using SHELXS and SHELXL programs [10]. All the non-hydrogen atoms 
were revealed in the first difference Fourier map itself. All hydrogen atoms were positioned geometrically (C–H = 
0.93 Å) and refined using a riding model with Uiso(H) = 1.2 Ueq (C) and Uiso(H) = 1.5 Ueq (O) for hydroxy group. 
After several cycles of refinement, the final difference Fourier map showed peaks of no chemical significance and 
the residual is saturated. The geometrical calculations were carried out using the program PLATON [11]. The 
molecular and packing diagrams were generated using the software MERCURY [12]. The details of the crystal 
structure and data refinement are given in Table 1. The list of bond lengths and bond angles and torsion angle of the 
non-hydrogen atoms are given in Table 2, 3, 4, 5, 6 and Table 7. Figure-1 represents the ORTEP of the molecule 
with thermal ellipsoids drawn at 50% probability.   
 
 
Figure-1: ORTEP diagram of the molecule with thermal ellipsoids drawn at 50% probability 
 
RESULTS AND DISCUSSION 
 
In the molecular structure of the title compound, the bond lengths and bond angles do not show large deviations and 
are comparable with the standard values. The dihedral angle between the mean planes of thiophene ring 
(S1/C3/C4/C1/C2) and the phenyl ring (C9/C10/C12/C14/C13/C11) is 52.98°. The dihedral angle between the mean 
planes of the thiophene ring (S1/C3/C4/C1/C2) and the pyrazole ring (N1/N2/C6/C7/C5) is 3.99°. The dihedral 
angle between the mean planes of the phenyl ring (C9/C10/C12/C14/C13/C11) and the pyrazole ring 
(N1/N2/C6/C7/C5) is 48.99°.The bond length between C14-Cl1, C8-O1, N1-N2, C4-C5, N1-C9, C1-S1, S1-C4 
AND C6-C8 are 1.731 Å, 1.205 Å, 1.363 Å, 1.460 Å, 1.421 Å, 1.703 Å, 1.717 Å and 1.450 Å respectively. The 
bond angle between C1-S1-C4, C4-C5-N2, C5-N2-N1, N2-N1-C9, O1-C8-C6, C9-C14-Cl1 and C3-C4-C5 are 
91.771°, 117.35°, 105.59°, 118.68°, 128.19°, 120.86° and 131.04° respectively. The torsion angle between C4-C5-
N2-N1, N1-C9-C14-Cl1, C1-S1-C4-C5 and O1-C8-C6-C7 are 117.12°, -0.23°, -178.95° and -174.01° respectively. 
The crystal structure is stabilized by intramolecular C---H...O hydrogen bonds. Figure-2 represents the packing 
diagram of the molecule when viewed down along the α axis.  
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Figure 2: Packing diagram of the molecules when viewed down along the a axis 
 
Table 1. Crystal data and structure refinement details of molecule 
Empirical formula C14H9ClN2OS 
Formula weight 288.75 
Temperature 296K 
Wavelength 1.54178 Å 
Reflns. for cell determination 3359 
θ Range for above 4.31º to 64.49 º 
Crystal system Triclinic 
Space group P-1 
Cell dimensions α= 7.2562(12) Å      β= 8.6896(11) Å     c =11.4407(16) Å 
α= 109.168(7) º       β= 105.648(7) º        ᵞ= 94.4099(8) º 
Volume 645.18(17) Å 3 
Z 2 
Density(calculated) 1.486 Mgm-3 
Absorption coefficient 4.068 mm-1 
F000 296 
Crystal size 0.200× 0.200×0.200 mm 
θ range for data collection 4.31º to 64.49 º 
Index ranges -3 ≤ h ≤ 8        -9 ≤  k ≤ 10         -13 ≤  l ≤ 12 
Reflections collected 3359 
Independent reflections 1979 [ Rint  = 0.0431] 
Absorption correction Multi-scan 
Refinement method Full matrix least-squares on F 2 
Data/ restraints/ parameters 1979 / 0 / 173 
Goodness-of-fit on F2 1.031 
Final [I >2σ(Ι )]  R1 = 0.0658, ωR2 = 0.1710 
R indices (all data) R1 = 0.0773, ωR2 = 0.1821 
Extinction coefficient 0.017(3) 
Largest diff. peak and hole 0.555 and -0.473e Å-3 
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Table 2: Atomic coordinates and equivalent thermal parameters of the non-hydrogen toms 
Atom x Y z Ueq 
Cl1 0.25000(16) 0.19150(17) 0.03204(11) 0.0793(5) 
S1 0.17129(14) 0.86380(10) 0.50892(9) 0.0482(3) 
O1 0.3831(4) 0.3738(3) 0.6354(3) 0.0603(10) 
N1 0.0608(4) 0.3730(3) 0.2314(3) 0.0353(8) 
N2 0.0826(4) 0.5314(3) 0.3154(3) 0.0340(8) 
C1 0.2772(6) 0.9879(4) 0.6682(4) 0.0531(11) 
C2 0.3563(6) 0.9030(5) 0.7417(4) 0.0536(12) 
C3 0.3340(5) 0.7322(4) 0.6684(3) 0.0425(11) 
C4 0.2350(4) 0.6916(4) 0.5401(3) 0.0321(10) 
C5 0.1821(4) 0.5331(4) 0.4312(3) 0.0303(9) 
C6 0.2237(4) 0.3726(4) 0.4228(3) 0.0358(10) 
C7 0.1435(5) 0.2778(4) 0.2941(3) 0.0390(11) 
C8 0.3201(5) 0.3054(4) 0.5187(4) 0.0443(11) 
C9 -0.0461(5) 0.3315(4) 0.0980(3) 0.0365(10) 
C10 0.0241(5) 0.2490(4) -0.0013(3) 0.0430(11) 
C11 -0.0812 (6) 0.2151 (5) -0.1301 (4) 0.0524 (12) 
C12 -0.2561 (6) 0.2654 (5) -0.1599(4) 0.0509(12) 
C13 -0.3273(6) 0.3476(5) -0.0624(4) 0.0555(14) 
C14 -0:2235(5) 0:3829(5) 0:0669(4) 0:0480(12) 
 
Table-3: Atomic coordinates and equivalent thermal parameters of the hydrogen atom 
Atom x Y z Ueq 
H1 0.27990 1.10150 0.70040 0.0630 
H2 0.41890 0.95100 0.83100 0.0640 
H3 0.38200 0.65590 0.70420 0.0510 
H7 0.14580 0.16580 0.25610 0.0470 
H8 0.33500 0.19560 0.48600 0.0530 
H10 -0.27220 0.44060 0.13260 0.0580 
H11 -0.44720 0.38030 -0.08310 0.0660 
H12 -0.32640 0.24380 -0.24640 0.0610 
H13 -0.03300 0.15810 -0.19640 0.0630 
 
Table 4: Anisotropic thermal parameters of the non-hydrogen atoms 
Atom  U11 U22 U33 U23 U13 U12 
Cl1 0.0654(8) 0.1217(11) 0.0616(8) 0.0332(7) 0.0267(6) 0.0546(7) 
S1 0.0604(6) 0.0385(6) 0.0487(6) 0.0250(4) 0.0081(4) 0.01759(4) 
O1 0.0658(18) 0.0632(17) 0.0589(19) 0.0422(15) 0.0029(14) 0.0227(13) 
N1 0.0402(15) 0.0338(14) 0.0381(15) 0.0209(12) 0.0105(12) 0.0133(11) 
N2 0.0358(14) 0.0365(14) 0.0382(15) 0.0230(12) 0.0114(12) 0.0139(11) 
C1 0.060(2) 0.0371(18) 0.056(2) 0.0151(17) 0.0101(19) 0.0113(16) 
C2 0.058(2) 0.053(2) 0.043(2) 0.0163(17) 0.0048(18) 0.0170(17) 
C3 0.0467(19) 0.0440(18) 0.042(2) 0.0237(15) 0.0091(15) 0.0191(14) 
C4 0.0309(16) 0.0339(16) 0.0400(18) 0.0216(14) 0.0122(13) 0.0130(12) 
C5 0.0283(15) 0.0375(16) 0.0364(17) 0.0239(14) 0.0127(13) 0.0139(12) 
C6 0.0364(17) 0.0366(17) 0.046(2) 0.0282(15) 0.0122(15) 0.0164(13) 
C7 0.0424(18) 0.0371(17) 0.049(2) 0.0261(16) 0.0169(16) 0.0158(14) 
C8 0.046(2) 0.0430(19) 0.054(2) 0.0319(18) 0.0107(18) 0.0192(15) 
C9 0.0388(17) 0.0371(16) 0.0380(18) 0.0217(14) 0.0090(14) 0.0075(13) 
C10 0.0431(19) 0.048(2) 0.044(2) 0.0224(17) 0.0152(16) 0.0126(15) 
C11 0.058(2) 0.057(2) 0.043(2) 0.0192(18) 0.0167(18) 0.0079(18) 
C12 0.053(2) 0.060(2) 0.039(2) 0.0282(18) 0.0031(17) 0.0011(17) 
C13 0.043(2) 0.072(3) 0.056(2) 0.038(2) 0.0034(18) 0.0146(18) 
C14 0.046(2) 0.061(2) 0.046(2) 0.0285(18) 0.0140(17) 0.0217(17) 
 
Table 5: Bond lengths (Å). 
Atoms Length Atoms Length Atoms Length Atoms Length 
Cl1-C10 1.731(4) C4-C5 1.460(5) C1-C2 1.339(6) C12-C13 1.366(6) 
S1-C1 1.703(4) C5-C6 1.428(5) C2-C3 1.416(6) C13-C14 1.384(6) 
S1-C4 1.717(4) C6-C7 1.361(4) C3-C4 1.359(4)   
O1-C8 1.205(5) C6-C8 1.450(5) C1-H1 0.9300 C11-H13 0.9300 
N1-N2 1.364(4) C9-C10 1.378(5) C2-H2 0.9300 C12-H12 0.9300 
N1-C7 1.339(5) C9-C14 1.389(5) C3-H3 0.9300 C13-H11 0.9300 
N1-C9 1.421(4) C10-C11 1.384(5) C7-H7 0.9300 C14-H10 0.9300 
N2-C5 1.321(4) C11-C12 1.367(6) C8-H8 0.9300   
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Table 6: Bond angles (º) 
Atoms Angle Atoms Angle Atoms Angle Atoms Angle 
C1-S1-C4 91.77(17) C5-C6-C8 133.4(3) C4-C5-C6 132.0(3) C9-C14-C13 119.6(4) 
N2-N1-C7 111.1(3) C7-C6-C8 122.4(3) C5-C6-C7 104.2(3)   
N2-N1-C9 118.7(3) N1-C7-C6 108.5(3) N2-C5-C6 110.6(3) C12-C13-C14 120.9(4) 
C7-N1-C9 130.2(3) O1-C8-C6 128.2(4) S1-C1-H1 124.00 C6-C8-H8 116.00 
N1-N2-C5 105.6(3) N1-C9-C10 122.3(3) C2-C1-H1 124.00 C10-C11-H13 120.00 
S1-C1-C2 112.2(3) N1-C9-C14 118.7(3) C1-C2-H2 124.00 C12-C11-H13 120.00 
C1-C2-C3 112.5(4) C10-C9-C14 118.8(3) C3-C2-H2 124.00 C11-C12-H12 120.00 
C2-C3-C4 112.8(3) C11-C10-C9 120.9(3) C2-C3-H3 124.00 C13-C12-H12 120.00 
S1-C4-C3 110.7(3) C11-C10-C11 118.3(3) C4-C3-H3 124.00 C12-C13-H11 120.00 
S1-C4-C5 118.2(2) C9-C10-C11 120.8(4) N1-C7-H7 126.00 C14-C13-H11 119.00 
C3-C4-C5 131.0(3) C10-C11-C12 120.0(4) C6-C7-H7 126.00 C9-C14-H10 120.00 
N2-C5-C4 117.4(3) C11-C12-C13 119.8(4) O1-C8-H8 116.00 C13-C14-H10 120.00 
 
Table 7: Torsion angles (º) 
Atoms Angle Atoms Angle 
C4-S1-C1-C2 -0.3(4) C3-C4-C5-C6 -3.1(6) 
C1-S1-C4-C3 -0.2(3) N2-C5-C6-C7 0.6(4) 
C1-S1-C4-C5 -179.0(3) N2-C5-C6-C8 -177.5(4) 
C7-N1-N2-C5 0.6(4) C4-C5-C6-C7 -176.8(3) 
C9-N1-N2-C5 178.5(3) C4-C5-C6-C8 5.1(6) 
N2-N1-C7-C6 -0.2(4) C5-C6-C7-N1 -0.2(4) 
C9-N1-C7-C6 -177.8(3) C8-C6-C7-N1 178.1(3) 
N2-N1-C9-C10 130.5(4) C5-C6-C8-O1 3.8(7) 
N2-N1-C9-C14 -46.3(5) C7-C6-C8-O1 -174.0(4) 
C7-N1-C9-C10 -52.1(6) N1-C9-C10-Cl1 -0.2(5) 
C7-N1-C9-C14 131.0(4) N1-C9-C10-Cl1 -178.0(4) 
N1-N2-C5-C4 177.1(3) C14-C9-C10-Cl1 176.6(3) 
N1-N2-C5-C6 -0.8(4) C14-C9-C10-Cl1 -1.1(6) 
S1-C1-C2-C3 0.7(5) N1-C9-C14-C13 178.3(4) 
C1-C2-C3-C4 -0.9(5) C10-C9-C14-C13 1.3(6) 
C2-C3-C4-S1 0.6(4) Cl1-C10-C11-C12 -177.0(4) 
C2-C3-C4-C5 179.2(4) C9-C10-C11-C12 0.8(6) 
S1-C4-C5-N2 -2.0(4) C10-C11-C12-C13 -0.7(7) 
S1-C4-C5-C6 175.3(3) C11-C12-C13-C14 0.9(7) 
C3-C4-C5-N2 179.5(4) C12-C13-C14-C9 -1.2(7) 
 
Antimicrobial activity 
Antimicrobial activity of the synthesized compounds was done by paper disc diffusion method [13]. The compound 
(3) at the concentration of 50 µg/mL in methanol in the nutrient agar media were screened for their antifungal 
activity against Aspergillus niger, Aspergillus flavus, C. albicans, Fusarium oxysporium. The antibiotic nystatin was 
used as positive reference drug. The screening tests were performed in triplicate and the results were taken as a 
mean of three determinations and were summarized in Table 8.  
 
Minimum inhibitory concentrations (MICs) were determined by broth dilution technique [14]. The nutrient broth, 
which contain logarithmic serially two-fold diluted amount of test compound and controls were inoculated with 
approximately 5 x 105 cfu of actively dividing bacteria cells. The fungal cultures were incubated for 72 hrs at 37 °C, 
the growth was monitored spectrophotometrically. The experiments were carried out in triplicate; the results were 
taken as a mean of three determinations and were summarized in Table 8. 
 
Table-8: Zone of Inhibition (diameter) at 25 µg/mL concentrations (X) in mm and MICs (Y) in µg/mL of the synthesized compound, (3) 
tested against fungal stains by disc diffusion method and micro dilution method respectively 
Compound A. niger A. flavus C. albicans 
 X Y X Y X Y 
3 18 23 20 24 17 36 
nystatin 35 20 30 18 32 22 
The results are expressed as mean of three determinations (n=3); nystatin (50 µg per disc) = positive control 
 
CONCLUSION 
 
In the present work, a new molecule 1-(2-chlorophenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carboxaldehyde 
synthesized and characterized by spectral and crystallographic studies. The molecule was evaluated for its antifungal 
activity against tested fungal strains. 
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